胆汁酸,肠道微生物群,以及对肝细胞癌的治疗见解
Yang Song1,2, Harry Ch Lau1, Xiang Zhang1
1Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
改变胆汁酸 (BA) 代谢和肠道微生物群的变化是肝癌 (肝细胞癌,HCC) 的关键. 了解这种交叉通话为HCC提供了新的治疗策略.
科学领域:
- 胃肠病学和肝病学
- 微生物学 微生物学
- 在瘤学瘤学.
背景情况:
- 肝细胞癌 (HCC) 是全球主要的肝癌.
- 胆汁酸 (BAs) 和肠道微生物群的相互作用在HCC发育中至关重要.
- 肠道功能失调会破坏BA平衡,促进肝炎和纤维化.
研究的目的:
- 审查BA代谢和肠道微生物群在HCC中的作用.
- 探索BA和肠道微生物在肝癌发生过程中的复杂交叉.
- 讨论针对HCC的BA代谢和肠道微生物群的治疗策略.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 对HCC中BA代谢和肠道微生物群的研究分析.
- 治疗干预措施的评估.
主要成果:
- 肠道微生物群对BA代谢的调节失调与HCC有关.
- BA-微生物群交叉影响肝炎,纤维化和癌症进展.
- 各种治疗策略在调节BA代谢和肠道微生物群方面表现有前途.
结论:
- 了解BA-微生物群相互作用对于HCC病变发生至关重要.
- 准BA代谢和肠道微生物群为肝癌提供了新的治疗途径.
- 对这种交叉的进一步研究可以导致创新的HCC治疗方法.
更多相关视频
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Role of Transporters
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
